Cite
HARVARD Citation
Kalincik, T. et al. (2018). Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis. Multiple sclerosis. pp. 1617-1626. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kalincik, T. et al. (2018). Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis. Multiple sclerosis. pp. 1617-1626. [Online].